These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 18538736)

  • 1. DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications.
    Jiang X; Tan J; Li J; Kivimäe S; Yang X; Zhuang L; Lee PL; Chan MT; Stanton LW; Liu ET; Cheyette BN; Yu Q
    Cancer Cell; 2008 Jun; 13(6):529-41. PubMed ID: 18538736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.
    Kawamoto K; Hirata H; Kikuno N; Tanaka Y; Nakagawa M; Dahiya R
    Int J Cancer; 2008 Aug; 123(3):535-42. PubMed ID: 18404682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class I and III HDACs and loss of active chromatin features contribute to epigenetic silencing of CDX1 and EPHB tumor suppressor genes in colorectal cancer.
    Rönsch K; Jäger M; Schöpflin A; Danciu M; Lassmann S; Hecht A
    Epigenetics; 2011 May; 6(5):610-22. PubMed ID: 21393996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation.
    Zhang YW; Staal B; Dykema KJ; Furge KA; Vande Woude GF
    PLoS One; 2012; 7(6):e38955. PubMed ID: 22701735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines.
    Liu Y; Hong Y; Zhao Y; Ismail TM; Wong Y; Eu KW
    Cancer Invest; 2008 Jul; 26(6):575-82. PubMed ID: 18584348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction.
    Gan XQ; Wang JY; Xi Y; Wu ZL; Li YP; Li L
    J Cell Biol; 2008 Mar; 180(6):1087-100. PubMed ID: 18347071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of tumor-specific splice variant Rac1b by dishevelled promotes canonical Wnt signaling and decreased adhesion of colorectal cancer cells.
    Esufali S; Charames GS; Pethe VV; Buongiorno P; Bapat B
    Cancer Res; 2007 Mar; 67(6):2469-79. PubMed ID: 17363564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt2 complements Wnt/β-catenin signaling in colorectal cancer.
    Jung YS; Jun S; Lee SH; Sharma A; Park JI
    Oncotarget; 2015 Nov; 6(35):37257-68. PubMed ID: 26484565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the human naked cuticle homolog NKD1 found in colorectal cancer alter Wnt/Dvl/beta-catenin signaling.
    Guo J; Cagatay T; Zhou G; Chan CC; Blythe S; Suyama K; Zheng L; Pan K; Qian C; Hamelin R; Thibodeau SN; Klein PS; Wharton KA; Liu W
    PLoS One; 2009 Nov; 4(11):e7982. PubMed ID: 19956716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer.
    Fahrner JA; Eguchi S; Herman JG; Baylin SB
    Cancer Res; 2002 Dec; 62(24):7213-8. PubMed ID: 12499261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs.
    Deng G; Kakar S; Okudiara K; Choi E; Sleisenger MH; Kim YS
    Clin Cancer Res; 2009 Mar; 15(5):1519-26. PubMed ID: 19223499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway.
    Kim MS; Yoon SK; Bollig F; Kitagaki J; Hur W; Whye NJ; Wu YP; Rivera MN; Park JY; Kim HS; Malik K; Bell DW; Englert C; Perantoni AO; Lee SB
    J Biol Chem; 2010 May; 285(19):14585-93. PubMed ID: 20220130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer.
    Mostovich LA; Prudnikova TY; Kondratov AG; Gubanova NV; Kharchenko OA; Kutsenko OS; Vavilov PV; Haraldson K; Kashuba VI; Ernberg I; Zabarovsky ER; Grigorieva EV
    Epigenetics; 2012 Aug; 7(8):930-9. PubMed ID: 22805760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of Wnt5a during colon cancer metastasis involves histone modifications.
    Li Q; Chen H
    Epigenetics; 2012 Jun; 7(6):551-8. PubMed ID: 22522911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression.
    Li Y; Bavarva JH; Wang Z; Guo J; Qian C; Thibodeau SN; Golemis EA; Liu W
    Oncogene; 2011 Jun; 30(23):2633-43. PubMed ID: 21317929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.
    Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM
    Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.